False diagnoses are used to mask inappropriate use of antipsychotic drugs on patients with dementia, a practice called chemical restraint, a government watchdog report said.

Watchdog report flags antipsychotic misuse in nursing homes, revealing false schizophrenia diagnoses to inflate CMS ratings and compromise care.

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

Discover innovative schizophrenia treatment options targeting cognitive symptoms for improved patient independence.

US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...

New research urges reclassifying schizophrenia as a neurodevelopmental syndrome—advancing diagnosis, care, and public ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

Schizophrenia affects 1% of the global population and is caused by a complex interplay between at least 280 genes and environmental factors like childhood trauma and early cannabis use. Patients with ...

One of the symptoms of schizophrenia is difficulty incorporating new information about the world. This can lead patients to struggle with making decisions and, eventually, to lose touch with reality.

News and commentary from the psychiatry world ...

Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral ...

Dementia patients are given antipsychotics, which FDA warns may increase the risk for deat ...